Sunitinib in metastatic renal cell carcinoma patients with brain metastases
Martin Gore(Imperial College London), Cezary Szczylik(Wojskowy Instytut Medycyny Lotniczej)
Cited by 142
Related Papers
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
|The Lancet|2008|642
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
|Scientific Reports|2016|224
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
|Clinical Cancer Research|2014|160
Axitinib for the Management of Metastatic Renal Cell Carcinoma
|Drugs in R&D|2011|147